1h ago
Sensex drops 524 points and Nifty 50 loses 145 as geopolitical risks and oil prices pressure Indian stocks
Indian equities opened sharply lower, with the Sensex down 524.12 points and the Nifty 50 off 145.20 points. Brent crude rose 1.88% to USD 84.86 a barrel while gold gained 0.34% to USD 4,015.28 an ounce, and Dow Jones Futures fell 167.87 points. The selloff was widely linked to escalating Middle East military tensions, hawkish signals from global central banks and key U.S. inflation data approaching, which has pushed investors away from risk assets and added a geopolitical premium to commodities, according to ANI.
Selected
1h ago
1h ago
HCLTech shares slide after firm keeps fiscal 2027 outlook unchanged amid demand uncertainty
HCLTech reported first-quarter profit and revenue that beat expectations, but kept its fiscal 2027 constant-currency revenue growth guidance at 1%-4% and its EBIT margin guidance at 17.5%-18.5%. Several brokerages said the unchanged outlook underscores ongoing softness in tech spending by clients in financial services, telecom and manufacturing, alongside pressure from advanced AI tools. While bookings improved, the market read the steady guidance as confirmation that demand remains fragile.
1h ago
1h ago
Sensex, Nifty slip 0.6% at open on July 14, 2026 as US-Iran tensions lift oil prices
On July 14, 2026, markets turned cautious after a fresh escalation between the US and Iran in the Strait of Hormuz, with Washington saying it plans to impose shipping fees and neither side backing down. Brent crude jumped 9% in one session and briefly touched $86.60 a barrel, heightening worries about potential supply disruptions. India’s Sensex and Nifty fell 0.6% at the open, while the rupee weakened 33 paise to 95.95 per dollar.
Selected
1h ago
2h ago
Alembic Pharma shares slide 2% after USFDA warning letter tied to Vadodara bioequivalence facility
The US Food and Drug Administration issued a warning letter dated July 10, 2026, to a clinical investigator linked to a bioequivalence study conducted at Alembic Pharma’s Vadodara facility. The letter followed an inspection conducted between March 3 and March 7, 2025, and cited issues related to the Informed Consent Form used in the study. Alembic said the observations are not related to data integrity and that the warning letter does not restrict facility operations or have a material financial impact at this stage. The company said the matter could slow the review of its abbreviated new drug application (ANDA) submissions to the USFDA, raising investor concerns about export risks.
2h ago
2h ago
Adani Enterprises jumps about 41% in 2026 as Rs 15,000 crore QIP revives investor appetite
Adani Enterprises raised Rs 15,000 crore through a qualified institutional placement, drawing strong participation from global and domestic institutions. The company said it will use the proceeds to fund expansion across copper smelting, airports, roads, data centres and green energy, alongside debt repayment and general corporate purposes. Morgan Stanley forecasts copper EBITDA of Rs 3,670 crore by FY30.
2h ago
2h ago
Gold rebounds after two-week low as markets await June U.S. CPI
Gold prices rebounded in early Tuesday trading after slipping to a two-week low in the previous session, as investors positioned ahead of June U.S. CPI data. Traders have increased bets on a September Federal Reserve rate hike, with the implied probability rising to around 76% from 57% a week earlier. Spot gold was quoted at $4,013.93 an ounce, while U.S. gold futures added 0.4%. Oil prices climbed on escalating U.S.-Iran tensions, but rate expectations continued to dominate bullion sentiment.
2h ago
2h ago
Brokerages stay cautious on HCLTech after FY26 Q1 beat as Citi downgrades to Sell and Nomura lifts target to Rs 1,290
HCL Technologies reported FY26 Q1 results, with net profit up 20% year on year to Rs 4,624 crore and revenue rising 14% to Rs 34,579 crore, while operating margin improved to 16.9%. The company kept its FY27 revenue growth guidance of 1-4% and EBIT margin guidance of 17.5-18.5%, and announced a Rs 3,500 crore investment in an AI data centre. Broker views diverged, with Citi cutting the stock to Sell, Nomura maintaining Buy and raising its target to Rs 1,290, while CLSA, Goldman Sachs and HSBC stayed broadly cautious and neutral.
2h ago
2h ago
TSMC seen posting fifth straight record quarter as Q2 net profit jumps 59% to T$632.6 billion
TSMC is expected to report second-quarter net profit of $19.65 billion, up 59% year on year, setting a record high for a fifth straight quarter. Revenue is projected to rise 36% from a year earlier, also beating expectations. Analysts attribute the momentum to sustained AI infrastructure spending that is lifting demand for advanced manufacturing and CoWoS packaging. They also expect TSMC may raise its full-year revenue growth guidance, currently set at "above 30%", and update its capital spending outlook.
2h ago